Medicenna Therapeutics (MDNAF) Q3 2024 Earnings

2AugConfirmed
Feb 20
May 20
Aug 20
Q3 2024
-0.07
-0.06
-0.05
-0.03

Details

Expected EPS
-0.0328815
Actual EPS
-0.036535
Surprise EPS
-0
Surprise Percent
+11.11%

Description

Medicenna Therapeutics (MDNAF) has reported earnings of -0.036535 per share for Q3 2024.

0 Comments

Share your thoughts